MedCity News

MARCH 13, 2023

Each year, nonprofit ECRI creates a list of the industry’s top ten patient safety concerns. This year, the pediatric mental health crisis topped the list, above other important issues like violence against healthcare staff and clinicians being expected to work outside their scope of practice.

Safety 244

Safety Patients Healthcare Healthcare 244

MedCity News

DECEMBER 26, 2022

The FHIR APIs mandated by CMS are only one data format, designed for the fast exchange of electronic health records.There’s a larger category of APIs that will help us provide a simpler, more integrated process: experience APIs.

Electronics 264

Electronics Patients 264

MedCity News

JUNE 15, 2023

Now that Medicaid redeterminations have resumed, Walgreens is supporting patients by educating them about renewals and helping them navigate through the process, execs said at AHIP 2023 in Portland.

Patients 246

Patients Education 246

Fierce Pharma

APRIL 18, 2023

Embracing Personalization in Biopharma Patient Support Programs mteefey Tue, 04/18/2023 - 14:48

Biopharma 234

Biopharma Patients 234

Fierce Pharma

APRIL 6, 2023

Pfizer escapes proposed class action lawsuit over patient copay assistance esagonowsky Thu, 04/06/2023 - 11:03

Patients 246

Patients 246

Fierce Pharma

APRIL 27, 2023

Quitting Lilly's obesity drug tirzepatide may be difficult for many patients, exec says kdunleavy Thu, 04/27/2023 - 15:08

Patients 258

Patients 258

MedCity News

AUGUST 15, 2023

The second quarter of 2023 ended with 309 active drug shortages, the highest total in nearly a decade, according to a new report from ASHP.

Patients 246

Patients Healthcare Healthcare 246

MedCity News

JANUARY 2, 2023

with the right technology, healthcare organizations in the year ahead can become more efficient, make quality care accessible to more people, reduce their recruiting and hiring costs, prevent mistakes, and deliver better outcomes for themselves, their workers and their patients.

Healthcare 306

Healthcare Healthcare Recruitment Patients 306

Fierce Pharma

MARCH 17, 2023

Astellas, Pfizer look to broaden Xtandi’s patient base with new prostate cancer win after 8 years aliu Fri, 03/17/2023 - 10:22

Patients 224

Patients 224

MedCity News

NOVEMBER 29, 2023

At RSNA 2023, GE HealthCare announced the launch of a new AI suite designed to simplify radiologists’ workflows when reading mammograms and help them detect breast cancer in patients sooner. The new offering includes three AI tools made by iCAD.

Healthcare 312

Healthcare Healthcare Patients 312

MedCity News

DECEMBER 18, 2022

million patient records that were breached last year. As we look ahead to 2023, increasing cybersecurity budgets will be a necessity for healthcare organizations, despite their tight financial situations. In 2022, the healthcare sector is on track to meet or exceed the more than 50.4

Healthcare 70

Healthcare Healthcare Patients 70

MedCity News

JUNE 4, 2023

The study results were presented during the 2023 annual meeting of the American Society of Clinical Oncology. A Servier drug candidate acquired as part of a $1.8 billion deal kept a particular type of brain cancer from progressing in a Phase 3 clinical trial.

Patients 279

Patients Biopharma Pharma 279

MedCity News

DECEMBER 27, 2023

At RSNA, three major trends stood out: the integration of artificial intelligence (AI), a renewed focus on health equity, and a dedicated effort to enhance the patient experience.

Patients 264

Patients 264

MedCity News

APRIL 3, 2023

As health systems roll out new patient-facing technologies, they need to ensure that their patients are comfortable using these tools.

Patients 275

Patients Education 275

MedCity News

OCTOBER 2, 2023

healthcare stakeholders in 2023. Some of the main ideas covered in the report included Americans’ worsening physical and mental health, the industry’s shift away from traditional care pathways, and the way patients’ decision making is becoming increasingly driven by consumerism.

Healthcare 336

Healthcare Healthcare Marketing Patients 336

Fierce Pharma

MAY 16, 2023

BeiGene, Max Foundation team up to provide free Brukinsa to CLL patients in 29 low-income countries aliu Tue, 05/16/2023 - 15:35

Patients 193

Patients 193

Fierce Pharma

MARCH 6, 2023

ACC23: J&J's combo pill of Opsumit plus tadalafil improves blood flow in PAH patients kdunleavy Mon, 03/06/2023 - 08:29

Patients 187

Patients 187

Fierce Pharma

MARCH 6, 2023

ACC23: Bayer and J&J's Xarelto reduces ischemia risk for PAD patients after revascularization surgery kdunleavy Mon, 03/06/2023 - 07:09

Patients 178

Patients 178

MedCity News

JANUARY 22, 2023

More than half of technology leaders at the country’s top 50 health systems by net patient revenue said they’re investing more money into interoperability initiatives in 2023 than they did last year, according to a new report.

Patients 298

Patients Healthcare Healthcare 298

MedCity News

APRIL 19, 2023

Patients are struggling to find the right care, and that’s because the healthcare system is fragmented, according to Andrea Walsh, president and CEO of HealthPartners, an integrated healthcare provider and insurance company. Walsh made these comments Wednesday at the HIMSS 2023 conference in Chicago.

Healthcare 289

Healthcare Healthcare Healthcare Provider Insurance 289

Fierce Pharma

FEBRUARY 24, 2023

J&J wins EU backing for PARP combo Akeega in prostate cancer—but only in some patients aliu Fri, 02/24/2023 - 12:07

Patients 177

Patients 177

MedCity News

OCTOBER 4, 2023

Hospitals’ operating margins are still in a worse place than they were before the pandemic, but 2023 is shaping up to be a much more stable year for hospital finance than 2022, according to a new report from Kaufman Hall. Because this year hasn’t had any large Covid-19 surges, hospitals have seen less variability in patient volumes.

Patients 277

Patients 277

MedCity News

MAY 16, 2023

Patients can now find and book urgent care appointments in 22 states at more than 200 facilities on Zocdoc’s marketplace. In 2023, the company saw the volume of new urgent care facilities on Zocdoc grow by nearly 40% month over month on average and urgent care bookings grow by 80% month over month on average.

Patients 279

Patients 279

PM360

MAY 15, 2023

For nine years, we have looked to recognize those people in healthcare and life sciences who are making a mark on our industry, on patients, on colleagues, on the world. Master Educators: People who revolutionize the way patients/doctors learn and absorb information. Make a mark on the world that can’t be erased.”

Media 105

Media Education Marketing Sales 105

MedCity News

OCTOBER 13, 2023

At HLTH 2023, I had dozens of conversations with providers, digital health investors, startup CEOs and other players in the healthcare industry. When I got home, I compiled seven refreshingly honest takes I heard from them while at the conference.

Healthcare 298

Healthcare Healthcare Patients Medical 298

MedCity News

DECEMBER 5, 2022

An Amgen drug led to weight loss that was sustained, clinical data that support advancing the molecule to a Phase 2 test expected to start in early 2023. While AMG 133 trails rival products from Novo Nordisk and Eli Lilly, Amgen hopes to offer patients a dosing edge.

Patients 264

Patients Biopharma Pharma 264

MedCity News

MARCH 7, 2023

WeightWatchers will acquire Sequence, a platform that allows patients to have virtual appointments with a clinician, gives access to a dietitian and fitness coaching and provides prescription medications, including Ozempic and Wegovy.

Management 264

Management Prescription Medical Patients 264

Fierce Pharma

APRIL 26, 2023

FDA argues AstraZeneca, Merck's Lynparza only works in subset of prostate cancer patients aliu Wed, 04/26/2023 - 14:19

FDA 147

FDA Patients 147

MedCity News

FEBRUARY 21, 2023

To drive adoption, digital health solutions must solve real user problems, which means users cannot be an afterthought in developing these solutions. But it’s also important to recognize that end users aren’t the only group whose needs matter.

Patients 246

Patients 246

InCrowd

MARCH 13, 2023

How does a diverse patient audience feel about representation among their own physicians? Find out in our latest report from the 2023 Pharma Market Research Conference. The post Why Diversity Matters to Patients appeared first on InCrowd. The post Why Diversity Matters to Patients appeared first on InCrowd.

Patients 130

Patients Healthcare Provider Physicians Healthcare 130

MedCity News

JULY 17, 2023

Alzheimer’s disease patients in the earliest stages of their disease benefited the most from Eli Lilly drug donanemab, which is expected to receive an FDA decision by the end of 2023. Full results from the drug’s pivotal study were presented during the during the Alzheimer’s Association International Conference.

FDA 246

FDA Patients Biopharma Pharma 246

Fierce Pharma

MARCH 27, 2023

Discussing the rise of patient-centricity in life sciences jpiatt Mon, 03/27/2023 - 14:49

Patients 130

Patients 130

Fierce Pharma

MARCH 2, 2023

Harnessing Data to Improve Patient Access And Optimize Gross-to-Net jpiatt Thu, 03/02/2023 - 14:47

Patients 130

Patients 130

pharmaphorum

NOVEMBER 6, 2023

UK patient data project reaches one million volunteers Phil.Taylor Mon, 06/11/2023 - 08:55 Bookmark this

Patients 119

Patients 119

pharmaphorum

OCTOBER 16, 2023

Bayer adds QR code to pack to help blind patients Phil.Taylor Mon, 16/10/2023 - 09:58 Bookmark this

Patients 122

Patients 122

European Pharmaceutical Review

OCTOBER 10, 2023

Patients were 1.21 percent of patients treated with the nasal spray formulation of esketamine reported a TEAE that resolved same day. percent of quetiapine XR patients. percent of esketamine nasal spray-treated patients who reported a TEAE that persisted for more than one day, versus 74.7 However, 82.6 There were 53.6

Safety 109

Safety Leads Patients Pharmaceutical 109

European Pharmaceutical Review

DECEMBER 11, 2023

Results from MaaT Pharma’s Early Access Program (EAP) for its microbiome-based therapy MaaT013, have demonstrated positive overall response and overall survival rates in European patients with graft-versus-host disease (GvHD). The findings were presented at the 2023 American Society of Hematology (ASH) Annual Meeting.

Patients 119

Patients Pharma Pharmaceutical 119